Aytu Biopharma (AYTU) Other Gross PP&E Adjustments (2016 - 2025)
Aytu Biopharma (AYTU) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with -$1.9 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 24.94% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.9 million through Dec 2025, up 24.94% year-over-year, with the annual reading at -$201000.0 for FY2025, 110.11% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$1.9 million at Aytu Biopharma, up from -$2.4 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $2.0 million in Q2 2024, with the low at -$6.8 million in Q4 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$1.4 million, with a median of -$965500.0 recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments tumbled 5530.02% in 2021, then surged 4391.18% in 2023.
- Over 5 years, Other Gross PP&E Adjustments stood at -$6.8 million in 2021, then surged by 95.46% to -$307000.0 in 2022, then tumbled by 286.64% to -$1.2 million in 2023, then crashed by 111.12% to -$2.5 million in 2024, then grew by 24.94% to -$1.9 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$1.9 million, -$2.4 million, and -$201000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.